Like any industry, the next phase of growth in the pharmaceutical industry will be marked by consolidation. In addition to domestic M&As, the wave of inbound and outbound acquisitions are also expected to continue, says Jeffry Jacob, Engagement Manager, Tata Strategic Management Group.


Bookmark
Share
Get in Touch